mRNA-3927 PKPD Simulator
Indication: Propionic Acidemia
PK/PD simulator for mRNA-3927 in propionic acidemia. Moderna gene therapy for metabolic enzyme replacement.
Drug Overview
Clinical Context
- Molecular Target
- PCCA/PCCB
- Drug Class
- mRNA-LNP
- Therapeutic Area
- Rare Disease
- Indication
- Propionic Acidemia
- Route of Administration
- IV
Model Information
- Model Type
- mRNA PK → protein expression → biomarker PD
- Category
- PK/PD
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
Pharmacokinetic Parameters
Additional Parameters
| Parameter | Value |
|---|---|
| LNP CL | rapid (t½ ~0.5-2 h plasma) |
| dose range | 0.1-0.5 mg/kg IV q2w or q3w |
Parameters sourced from published population pharmacokinetic models. Values represent typical population estimates; individual patient parameters may vary.
About This Simulator
This interactive pharmacokinetic simulator for mRNA-3927 allows you to explore concentration-time profiles under different dosing scenarios. The underlying PK/PD model characterizes the pharmacokinetics of this mrna-lnp following iv administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration). The pharmacodynamic component links drug exposure to therapeutic or safety endpoints.
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the mRNA-3927 PK simulator?
This is a free, interactive pharmacokinetic simulator for mRNA-3927 used in Propionic Acidemia. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does mRNA-3927 belong to?
mRNA-3927 is classified as a mRNA-LNP that targets PCCA/PCCB. It is used in the Rare Disease therapeutic area.
What route of administration does this model simulate?
This simulator models IV administration of mRNA-3927. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a PK/PD model. PK/PD models link drug concentrations to pharmacological effects, allowing exploration of exposure-response relationships.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
Related Simulators
Ready to Simulate?
Launch the mRNA-3927 simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community